388610 — Gfc Life Science Co Balance Sheet
0.000.00%
- KR₩74bn
- KR₩72bn
- KR₩17bn
Annual balance sheet for Gfc Life Science Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | Annual Audited Accounts | ARS | ARS | ARS |
| Standards: | KAS | KAS | KAS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 1,210 | 625 | 1,483 | 1,538 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 1,717 | 2,214 | 2,086 | 1,764 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 3,699 | 3,402 | 4,396 | 3,947 |
| Net Property, Plant And Equipment | 12,797 | 13,623 | 12,334 | 14,501 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Other Long Term Assets | ||||
| Total Assets | 18,023 | 19,857 | 18,838 | 20,055 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 6,998 | 20,516 | 18,294 | 6,867 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 9,788 | 16,586 | 20,001 | 9,155 |
| Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Treasury Stock | ||||
| ESOP Debt Guarantee | ||||
| Other Equity | ||||
| Total Equity | 8,235 | 3,271 | -1,164 | 10,900 |
| Total Liabilities & Shareholders' Equity | 18,023 | 19,857 | 18,838 | 20,055 |
| Total Common Shares Outstanding | ||||
| Total Preferred Shares Outstanding |